3.0.0 1348 2023-01-11T13:37:37Z 2023-01-11T13:37:37Z Senate S 2017-06-13 115 ssfi00 Finance Committee Senate Standing Referred to 2017-06-13T21:26:56Z 2017-06-13 ssfi00 Finance Committee Senate Read twice and referred to the Committee on Finance. IntroReferral 2017-06-13 Introduced in Senate IntroReferral 10000 9 Library of Congress W000779 Sen. Wyden, Ron [D-OR] Ron Wyden D OR N C000141 Sen. Cardin, Benjamin L. [D-MD] Ben Cardin D MD 2017-06-13 True S000770 Sen. Stabenow, Debbie [D-MI] Debbie Stabenow D MI 2017-06-13 True G000555 Sen. Gillibrand, Kirsten E. [D-NY] Kirsten Gillibrand D NY E. 2017-06-13 True C000174 Sen. Carper, Thomas R. [D-DE] Thomas Carper D DE R. 2017-06-13 True C001088 Sen. Coons, Christopher A. [D-DE] Christopher Coons D DE A. 2017-06-13 True T000464 Sen. Tester, Jon [D-MT] Jon Tester D MT 2017-07-11 False D000622 Sen. Duckworth, Tammy [D-IL] Tammy Duckworth D IL 2017-08-02 False M000639 Sen. Menendez, Robert [D-NJ] Robert Menendez D NJ 2018-05-10 False H001069 Sen. Heitkamp, Heidi [D-ND] Heidi Heitkamp D ND 2018-07-25 False Health Civil actions and liability Corporate finance and management Government information and archives Inflation and prices Marketing and advertising Prescription drugs Research and development Health 00 2017-06-13 Introduced in Senate 2017-09-19T15:55:18Z Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017

This bill amends title XI (General Provisions) of the Social Security Act to require manufacturers of  drugs with specified percentage increases in their wholesale costs to submit to the Centers for Medicare & Medicaid Services (CMS) written justification for certain increases in drug prices. The CMS shall publish each submission, together with an easily understandable summary, on its website. Certain proprietary information may be excluded from publication, as specified by the bill.

A manufacturer that does not comply with the bill's requirements shall be subject to civil monetary penalties.

]]> Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017 Display Title Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017 Official Title as Introduced A bill to amend title XI of the Social Security Act to require drug manufacturers to publicly justify unnecessary price increases. Introduced in Senate IS Short Titles as Introduced Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017 Introduced in Senate 2017-06-13T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-115s1348is/xml/BILLS-115s1348is.xml 2017-06-13 Read twice and referred to the Committee on Finance. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.